• Media type: E-Article
  • Title: Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3
  • Contributor: Paulus, Jannik; Sewald, Norbert
  • imprint: Frontiers Media SA, 2022
  • Published in: Frontiers in Chemistry
  • Language: Not determined
  • DOI: 10.3389/fchem.2022.869639
  • ISSN: 2296-2646
  • Keywords: General Chemistry
  • Origination:
  • Footnote:
  • Description: <jats:p>An integrin α<jats:sub>V</jats:sub>β<jats:sub>3</jats:sub>-targeting linear RGD mimetic containing a small-molecule drug conjugate (SMDC) was synthesized by combining the antimitotic agent monomethyl auristatin E (MMAE), an enzymatically cleavable Val-Ala-PABC linker with a linear conjugable RGD mimetic. The structure proposal for the conjugable RGD mimetic was suggested upon the DAD mapping analysis of a previously synthesized small-molecule RGD mimetic array based on a tyrosine scaffold. Therefore, a diversifying strategy was developed as well as a novel method for the partial hydrogenation of pyrimidines in the presence of the hydrogenolytically cleavable Cbz group. The small-molecule RGD mimetics were evaluated in an ELISA-like assay, and the structural relationships were analyzed by DAD mapping revealing activity differences induced by structural changes as visualized in dependence on special structural motifs. This provided a lead structure for generation of an SMDC containing the antimitotic drug MMAE. The resulting SMDC containing a linear RGD mimetic was tested in a cell adhesion and an <jats:italic>in vitro</jats:italic> cell viability assay in comparison to reference SMDCs containing cRGDfK or cRADfK as the homing device. The linear RGD SMDC and the cRGDfK SMDC inhibited adhesion of α<jats:sub>V</jats:sub>β<jats:sub>3</jats:sub>-positive WM115 cells to vitronectin with IC<jats:sub>50</jats:sub> values in the low µM range, while no effect was observed for the α<jats:sub>V</jats:sub>β<jats:sub>3</jats:sub>-negative M21-L cell line. The cRADfK SMDC used as a negative control was about 30-fold less active in the cell adhesion assay than the cRGDfK SMDC. Conversely, both the linear RGD SMDC and the cRGDfK SMDC are about 55-fold less cytotoxic than MMAE against the α<jats:sub>V</jats:sub>β<jats:sub>3</jats:sub>-positive WM115 cell line with IC50 values in the nM range, while the cRADfK SMDC is 150-fold less cytotoxic than MMAE. Hence, integrin binding also influences the antiproliferative activity giving a targeting index of 2.8.</jats:p>
  • Access State: Open Access